Rafael MD - Aptose Biosciences Senior Officer

APS Stock  CAD 0.27  0.07  20.59%   

Executive

Rafael MD is Senior Officer of Aptose Biosciences
Age 52
Address 251 Consumers Road, Toronto, ON, Canada, M2J 4R3
Phone647 479 9828
Webhttps://www.aptose.com

Aptose Biosciences Management Efficiency

The company has return on total asset (ROA) of (1.3629) % which means that it has lost $1.3629 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.9413) %, meaning that it generated substantial loss on money invested by shareholders. Aptose Biosciences' management efficiency ratios could be used to measure how well Aptose Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Aptose Biosciences' Return On Capital Employed is very stable compared to the past year. As of the 23rd of November 2024, Return On Equity is likely to grow to 18.53, though Return On Tangible Assets are likely to grow to (3.75). At this time, Aptose Biosciences' Non Current Assets Total are very stable compared to the past year. As of the 23rd of November 2024, Fixed Asset Turnover is likely to grow to 0.84, while Total Assets are likely to drop about 12.3 M.
Aptose Biosciences has accumulated 1.01 M in total debt with debt to equity ratio (D/E) of 5.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Aptose Biosciences has a current ratio of 11.04, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Aptose Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Aptose Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aptose Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aptose to invest in growth at high rates of return. When we think about Aptose Biosciences' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 9 records

EXECUTIVE Age

Amy LevinOncolytics Biotech
N/A
MD FCAPMedicenna Therapeutics Corp
N/A
CBV CAMedicenna Therapeutics Corp
51
BBA CMOncolytics Biotech
N/A
PMP PEngOncolytics Biotech
N/A
BBA FCAOncolytics Biotech
N/A
Andres GutierrezOncolytics Biotech
58
Wayne MBAOncolytics Biotech
69
RN BSNOncolytics Biotech
N/A
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Toronto, Canada. APTOSE BIOSCIENCES operates under Biotechnology classification in Canada and is traded on Toronto Stock Exchange. It employs 22 people. Aptose Biosciences (APS) is traded on Toronto Exchange in Canada and employs 35 people. Aptose Biosciences is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Aptose Biosciences Leadership Team

Elected by the shareholders, the Aptose Biosciences' board of directors comprises two types of representatives: Aptose Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aptose. The board's role is to monitor Aptose Biosciences' management team and ensure that shareholders' interests are well served. Aptose Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aptose Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Philippe Ledru, Senior Officer
Fletcher Payne, CFO, VP
Janet CA, VP Fin
Rafael MD, Senior Officer
Roger BSc, Vice Operations
Marc Wiles, Senior Affairs
Brooks MBA, VP Controller
William Rice, Chairman, CEO and Pres

Aptose Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aptose Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Aptose Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving against Aptose Stock

  0.47WMT Walmart Inc CDRPairCorr
  0.36TSLA Tesla Inc CDRPairCorr
  0.31BRK Berkshire Hathaway CDRPairCorr
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Aptose Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aptose Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aptose Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aptose Biosciences Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.